Edward Woo Analyst PerformanceDirector of Research & Senior Analyst Equity Research at Ascendiant Capital MarketsEdward Woo is a stock analyst at Ascendiant Capital Markets across a range of sectors, covering 37 publicly traded companies. Over the past year, Edward Woo has issued 58 stock ratings, including and buy recommendations. While full access to Edward Woo's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Edward Woo's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings61 Last 10 YearsBuy Recommendations100.00% 60 Buy RatingsCompanies Covered37 Unique Companies Ratings Distribution60RatingsDistribution of strong buy, buy, hold, and sell ratings by Edward Woo.RatingPercentageCount Strong Buy0.0%0 ratings Buy100.0%60 ratings Hold0.0%0 ratings Sell0.0%0 ratingsthe majority (100.0%) have been Buy recommendations.Best & Worst CallsBest Call0000.0%DVLTAug 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%GNSSAug 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ94.6% of companies on NASDAQ35 companiesNYSEAMERICAN2.7% of companies on NYSEAMERICAN1 companyNYSEMKT2.7% of companies on NYSEMKT1 companyEdward Woo, an analyst at Ascendiant Capital Markets, currently covers 37 companies listed on NASDAQ, NYSEAMERICAN and NYSEMKT, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical20 companies54.1%Computer and Technology6 companies16.2%Business Services4 companies10.8%Retail/Wholesale3 companies8.1%Consumer Discretionary3 companies8.1%Energy1 company2.7%Edward Woo of Ascendiant Capital Markets specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Business Services companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE7 companies18.9%MED INSTRUMENTS7 companies18.9%INTERNET SOFTWARE5 companies13.5%INTERNET COMMERCE3 companies8.1%TECHNOLOGY SERVICES3 companies8.1%MED - DRUGS2 companies5.4%GAMING2 companies5.4%BIOFUELS1 company2.7%CONS SERVICES - MISC1 company2.7%MED PRODUCTS1 company2.7%COMP - NETWORKS1 company2.7%MED/DENTAL - SUPP1 company2.7%ADVERTISING/MKTG SVCS1 company2.7%MED - OUTP/HM CRE1 company2.7%PHARMACEUTICAL PREPARATIONS1 company2.7% About Edward WooMr. Woo serves as Director of Research and Senior Analyst for Ascendiant Capital Markets, LLC. Mr. Woo has over twenty years of experience – eight of which at Ascendiant – as an equity research analyst, during which time he has been responsible for industry and company analysis, financial modeling, formulating investment recommendations, publishing reports, and monitoring performance. He has made media appearances on CNBC and Bloomberg, and has been quoted in publications such as Reuters, MarketWatch, and the Los Angeles Times. Prior to Ascendiant, Mr. Woo was an equity analyst at Wedbush Securities in Los Angeles, California, and was employed by PricewaterhouseCoopers, Unisys Corporation, and Atlantic Richfield Company. Mr. Woo earned a Master’s degree in Business Administration from Yale School of Management and a Bachelor of Arts degree in Business Economics, magna cum laude, from the University of California, Los Angeles (UCLA). Mr. Woo is a Chartered Financial Analyst (CFA) and member of the CFA Institute, and is a California licensed Certified Public Accountant (inactive). He maintains FINRA Series 7, 16, 24, 63, 86, 87, and 99 securities registrations.Follow on LinkedIn Edward Woo's Ratings History at Ascendiant Capital Markets Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsTZOOTravelzoo8/26/2025Boost Price Target$9.69$26.00Buy$0.0000.00% ROIRNXTRenovoRx8/25/2025Boost Price Target$0.92$12.00Buy$0.0000.00% ROICINGCingulate8/22/2025Boost Price Target$3.99$62.00Buy$0.0000.00% ROIALZNAlzamend Neuro8/21/2025Lower Price Target$2.26$45.00Buy$0.0000.00% ROIALLRAllarity Therapeutics7/28/2025Initiated Coverage$1.02$9.00Buy$0.0000.00% ROIAYTUAytu BioPharma6/30/2025Initiated Coverage$2.10$12.00Buy$0.0000.00% ROIDUOTDuos Technologies Group6/16/2025Boost Price Target$7.78$11.00Buy$0.0000.00% ROISURGSurgePays6/16/2025Boost Price Target$2.58$9.00Buy$0.0000.00% ROIOTLKOncobiologics6/6/2025Lower Price Target$1.87$21.00Buy$0.0000.00% ROIPHUNPhunware6/6/2025Boost Price Target$2.93$12.50Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BSGMBiosig Technologies6/6/2025Boost Price Target$5.74$10.00Buy$0.0000.00% ROIAMTXAemetis6/6/2025Boost Price Target$1.72$20.00Buy$0.0000.00% ROIATOSAtossa Genetics6/6/2025Boost Price Target$0.86$7.50Buy$0.0000.00% ROILUCDLucid Diagnostics6/6/2025Boost Price Target$1.21$7.75Buy$0.0000.00% ROIPAVMPAVmed6/6/2025Lower Price Target$0.63$19.00Buy$0.0000.00% ROIQUBTQuantum Computing6/6/2025Boost Price Target$11.83$22.00Buy$0.0000.00% ROIKSCPKnightscope6/6/2025Lower Price Target$6.02$26.00Buy$0.0000.00% ROIGNSSGenasys6/6/2025Lower Price Target$1.74$5.50Buy$0.0000.00% ROIRNXTRenovoRx6/5/2025Boost Price Target$1.39$11.50Buy$0.0000.00% ROIMYOMyomo6/5/2025Boost Price Target$2.88$11.50Buy$0.0000.00% ROIPSTVPlus Therapeutics6/5/2025Boost Price Target$0.35$20.50Buy$0.0000.00% ROIVERBVerb Technology5/30/2025Boost Price Target$6.50$62.00Buy$0.0000.00% ROIINTZIntrusion5/30/2025Boost Price Target$1.35$11.00Buy$0.0000.00% ROITZOOTravelzoo5/30/2025Boost Price Target$13.40$25.00Buy$0.0000.00% ROISINTSintx Technologies5/30/2025Lower Price Target$2.79$28.00Buy$0.0000.00% ROIGRIGRI Bio5/27/2025Lower Price Target$1.20$34.00Buy$0.0000.00% ROICINGCingulate5/27/2025Boost Price Target$3.66$61.00Buy$0.0000.00% ROICOCHEnvoy Medical5/27/2025Boost Price Target$1.69$9.50Buy$0.0000.00% ROISOPASociety Pass5/27/2025Boost Price Target$1.39$15.00Buy$0.0000.00% ROIPDEXPro-Dex5/27/2025Boost Price Target$46.24$56.00Buy$0.0000.00% ROINRXPNRx Pharmaceuticals4/29/2025Boost Price Target$2.10$46.00Buy$0.0000.00% ROIDUOTDuos Technologies Group4/28/2025Boost Price Target$6.69$9.00Buy$0.0000.00% ROIQUBTQuantum Computing4/28/2025Boost Price Target$7.13$14.00Buy$0.0000.00% ROIKSCPKnightscope4/28/2025Lower Price Target$5.00$30.00Buy$0.0000.00% ROIBNZIBanzai International4/28/2025Lower Price Target$10.00$260.00Buy$0.0000.00% ROIRNXTRenovoRx4/28/2025Boost Price Target$0.99$11.00Buy$0.0000.00% ROISURGSurgePays4/22/2025Boost Price Target$2.68$8.75Buy$0.0000.00% ROISOPASociety Pass4/21/2025Lower Price Target$0.79$14.00Buy$0.0000.00% ROIBSGMBiosig Technologies4/21/2025Lower Price Target$0.58$2.50Buy$0.0000.00% ROIVERBVerb Technology4/21/2025Lower Price Target$4.20$60.00Buy$0.0000.00% ROICOCHEnvoy Medical4/21/2025Boost Price Target$1.34$9.25Buy$0.0000.00% ROISINTSintx Technologies4/21/2025Lower Price Target$1.75$30.00Buy$0.0000.00% ROINDRAENDRA Life Sciences4/21/2025Lower Price Target$3.67$50.00Buy$0.0000.00% ROICINGCingulate4/21/2025Lower Price Target$4.24$60.00Buy$0.0000.00% ROIPSTVPlus Therapeutics4/21/2025Boost Price Target$0.66$20.00Buy$0.0000.00% ROIPAVMPAVmed4/21/2025Boost Price Target$0.71$19.50Buy$0.0000.00% ROILUCDLucid Diagnostics4/21/2025Boost Price Target$1.21$7.50Buy$0.0000.00% ROIATOSAtossa Genetics4/21/2025Boost Price Target$0.62$7.25Buy$0.0000.00% ROIPHUNPhunware4/21/2025Lower Price Target$2.57$12.00Buy$0.0000.00% ROIMYOMyomo3/17/2025Boost Price Target$5.19$11.00Buy$0.0000.00% ROIALZNAlzamend Neuro3/17/2025Lower Price Target$6.09$180.00Buy$0.0000.00% ROIGRPNGroupon3/17/2025Boost Price Target$14.85$19.00Buy$0.0000.00% ROIDXRDaxor3/17/2025Boost Price Target$8.18$25.00Buy$0.0000.00% ROIAMTXAemetis3/17/2025Boost Price Target$1.68$19.00Buy$0.0000.00% ROITTWOTake-Two Interactive Software3/3/2025Boost Price Target$211.98$270.00Buy$0.0000.00% ROIEAElectronic Arts3/3/2025Boost Price Target$129.12$160.00Buy$0.0000.00% ROIOTLKOncobiologics2/24/2025Lower Price Target$1.56$24.00Buy$0.0000.00% ROIIGCIGC Pharma2/24/2025Boost Price Target$0.30$4.25Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.